CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Myriad Genetics (MYGN) Reports Q2 Loss, Misses Revenue Estimates

EarningsNegative
AI Analysis

Summary

Myriad Genetics reported Q2 earnings with a net loss and missed revenue estimates.

Importance:4/10
Sentiment:
-0.50
earningsQ2revenue_missloss
Related Companies

Read the original article

Published by yahoo_finance on July 30, 2026 10:00 PM

Read Original